Convatec announced that it has secured two new group purchasing agreements in the Enterostomal Therapy Products category with Premier, Inc., a technology‑driven healthcare improvement company that was acquired by Patient Square Capital on November 25 2025 for $28.25 per share. The contracts, which will become effective on April 1 2026, give Premier access to Convatec’s full ostomy product line, including the me+ support program, and provide Premier’s members with enhanced value and savings.
Continue reading for full analysis...